CD4+ and CD8+ T Cell Activation in Children with Hepatitis C - 25/02/16

Abstract |
Objectives |
To assess if peripheral T cell populations in children with chronic hepatitis C virus (HCV) infection would show evidence of activation/exhaustion and an attenuated functional response.
Study design |
Compared with adults, children with HCV infection have a higher rate of spontaneous viral clearance. In adults, chronic HCV has been linked to T cell exhaustion. Little is known of the immune status of children with HCV. Peripheral blood mononuclear cells were isolated from 16 children with HCV (6 males, 10 females; mean age 8.6 years, range 2-17), 16 age- and sex-matched control children without HCV infection, and 20 adults with chronic HCV. Multiparameter flow cytometry was performed to characterize T cell differences across the 3 groups.
Results |
Controls and children with HCV had similar levels of CD4+, CD8+, and γδ+ T cells. Children with HCV demonstrated a decrease in naïve T cells compared with control children and increased activation/exhaustion marker expression on both CD8+ and CD4+ T cells. Transcription factor analysis suggested functional activation of T cells in children with HCV; however, only the CD4+ subset had enhanced cytokine production (interferon gamma and interleukin-2) compared with control children.
Conclusions |
The HCV response in children is characterized by several changes in T cell phenotype. Many of these changes, such as increased T cell expression of programmed cell death-1, are similar to responses in adults. Of note, cytokine production by CD4+ helper T cells is increased in children with HCV compared with age- and sex-matched control children, which may influence long-term prognosis in children with HCV.
Le texte complet de cet article est disponible en PDF.Keyword : BD, EOMES, HCV, IFN, IL, PBMC, PD-1, SEB, T-bet, TIGIT
Plan
| Supported by the National Institutes of Health (NIH; R01-HD075549 and R56AI100991 [to H.R.]). The REDCap database was used for data collection and storage, supported through NIH/National Center for Research Resources (NCRR) Colorado Clinical and Translational Science Institute (CCTSI; UL1 TR000154). Clinical research support was provided by the Clinical Translational Research Centers (CTRC) at Children's Hospital Colorado, which is a part of the CCTSI, supported by Colorado Clinical and Translational Science Award (CTSA) from National Center for Research Resources (NCATS)/NIH (UL1 TR001082). M.S. is supported by NIH (5 T32 DK067009-10). The authors declare no conflicts of interest. |
Vol 170
P. 142 - mars 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
